Home › Funds › Lynx1 Capital Management LP › NUVB
Lynx1 Capital Management LP position in NUVB
NUVATION BIO INC · Health Care
Lynx1 Capital Management LP reported holding 16,029 shares of NUVB (NUVATION BIO INC) in its Q3 2026 13F filing — a position valued at US$90K, representing 0.01% of its reported portfolio and ranking #30 among its reported holdings. Lynx1 Capital Management LP has disclosed NUVB holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Lynx1 Capital Management LP's NUVB position evolved
Lynx1 Capital Management LP first disclosed a stake in NUVB in Q2 2026 at 16,029 shares (US$91K). Across 2 filings, Lynx1 Capital Management LP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 16,029 shares valued at US$90K.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 16.03K | $91.05K | New |
| Q3 2026 | 16.03K | $89.76K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About NUVB and 13F data
NUVB (NUVATION BIO INC) is a Health Care company. 56 other funds we track also report a position in NUVB — the largest reported positions include Decheng Capital LLC (US$145.3M), Context Capital Management, LLC (US$53.1M), Laurion Capital Management LP (US$43.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding NUVB
- Decheng Capital LLC 25.95M sh · $145.34M · Q3 2026
- Context Capital Management, LLC 52.00M sh · $53.13M · Q3 2026
- Laurion Capital Management LP 7.70M sh · $43.10M · Q3 2026
- Omega Fund Management, LLC 7.15M sh · $40.05M · Q3 2026
- Jones Hill Capital LP 4.49M sh · $25.13M · Q3 2026
- TANG CAPITAL MANAGEMENT LLC 3.30M sh · $18.48M · Q3 2026
- Redmile Group, LLC 3.03M sh · $16.97M · Q3 2026
- QVT Financial LP 15.50M sh · $15.93M · Q3 2026
- Duquesne Family Office LLC 2.27M sh · $12.71M · Q3 2026
- Knoll Capital Management, LLC 1.60M sh · $8.95M · Q3 2026
- ESSEX INVESTMENT MANAGEMENT CO LLC 1.34M sh · $7.53M · Q3 2026
- Nan Fung Group Holdings Ltd 1.33M sh · $7.43M · Q3 2026
More on Lynx1 Capital Management LP
FAQ
How long has Lynx1 Capital Management LP held NUVB?
Lynx1 Capital Management LP has disclosed NUVB holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Lynx1 Capital Management LP's current position in NUVB?
As of Q3 2026, Lynx1 Capital Management LP holds 16.03K shares of NUVB (NUVATION BIO INC), valued at $89.76K, representing 0.01% of its reported portfolio and ranking #30.
Has Lynx1 Capital Management LP been buying or selling NUVB?
In the latest 13F filing (Q3 2026), Lynx1 Capital Management LP held unchanged its position in NUVB.
Which other funds hold NUVB?
Other major institutional holders of NUVB include Decheng Capital LLC, Context Capital Management, LLC, Laurion Capital Management LP, among 56 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.